Colorectal cancer at age 30
An immunotherapy clinical trial at Duke has given Spencer Laird and his family new hope.
16-year study finds major health burden in single-ventricle heart
Duke researchers have found that nearly 90% of children born with single-ventricle heart disease have continuing health major health challenges into adolescence and sometimes beyond.
Duke researchers study immune system response to chemotherapy for colorectal cancer
Read the story on the Duke Cancer Institute blog.
The Brain’s Blueprint Maker
Debra Silver, PhD, is pursuing one of neuroscience’s biggest questions: What makes a human brain human? She researches it with the same mix of precision and adventure she brings to her passion for scuba diving.
The DNA repair duo cancers use to build ecDNA — and gain an advantage
Duke University School of Medicine researchers have discovered the keys to survival for a circular form of DNA that drives many aggressive cancers.
Immune cells play key role in regulating eye pressure linked to glaucoma
New research from Duke reveals that a specialized set of immune cells known as resident macrophages are essential in maintaining healthy eye pressure, pointing to a promising new target for therapies to prevent a major cause of blindness.
New blood test signals who is most likely to live longer, study finds
Research led by Duke Health in collaboration with the University of Minnesota has found that small RNA molecules known as piRNAs can accurately predict whether older adults are likely to survive at least two more years.